[M T]

Here's a brief (and reference-less) counterpoint on the ACE2 inhibitor thing: https://www.escardio.org/Councils/Counci...ame=iossmf

Thanks!  I have added this to my earlier post that has a table relating ACEI & ARB usage versus CFR. 

CFR should be viewed in conjunction with the demographics.  In the 4-hardest hit countries, the percent of population 65+ varies from 9% to 22.3%.   I added a column CFR/65+% to give such a view.  By that statistic, Iran's older population (9%) is really hit badly.  Italy is actually a bit better than China currently (but I'm sure it will grow worse as its epidemic matures).

In the US, 22.7% of the population is 65+.  That alone would suggest a relatively high CFR is coming.

[M T]

Here's a brief (and reference-less) counterpoint on the ACE2 inhibitor thing: https://www.escardio.org/Councils/Counci...ame=iossmf

Thanks!  I have added this to my earlier post that has a table relating ACEI & ARB usage versus CFR. 

CFR should be viewed in conjunction with the demographics.  In the 4-hardest hit countries, the percent of population 65+ varies from 9% to 22.3%.   I added a column CFR/65+% to give such a view.  By that statistic, Iran's older population (9%) is really hit badly.  Italy is actually a bit better than China currently (but I'm sure it will grow worse as its epidemic matures).

In the US, 22.7% of the population is 65+.  That alone would suggest a relatively high CFR is coming.